S. Barr

发表

ATR Kinase Activity Regulates the Intranuclear Translocation of ATR and RPA following Ionizing Radiation

K. Cimprich, Elbert Chang, Karlene A. Cimprich, 2003, Current Biology.

Reduced VEGF production, angiogenesis, and vascular regrowth contribute to the antitumor properties of dual mTORC1/mTORC2 inhibitors.

D. McDonald, P. Gokhale, D. Epstein, 2011, Cancer research.

Targeting TORC1/2 enhances sensitivity to EGFR inhibitors in head and neck cancer preclinical models.

Lin Wang, J. Grandis, S. Thomas, 2012, Neoplasia.

Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors.

S. Thomson, D. Epstein, J. Haley, 2008, Cancer research.

Ras‐induced colony formation and anchorage‐independent growth inhibited by elevated expression of Purα in NIH3T3 cells

Edward M. Johnson, E. Johnson, S. Barr, 2001, Journal of cellular biochemistry.

Association of Human Purα with the Retinoblastoma Protein, Rb, Regulates Binding to the Single-stranded DNA Purα Recognition Element (*)

Phang-lang Chen, Wen-Hwa Lee, Edward M. Johnson, 1995, The Journal of Biological Chemistry.

Cooperative action of cellular proteins YB-1 and Pur alpha with the tumor antigen of the human JC polyomavirus determines their interaction with the viral lytic control element.

G. Gallia, K. Khalili, R. Frisque, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Functional interaction of Purα with the Cdk2 moiety of cyclin A/Cdk2 ☆

C. Chu, D. Kohtz, Edward M. Johnson, 2005 .

Functional interaction of Puralpha with the Cdk2 moiety of cyclin A/Cdk2.

C. Chu, D. Kohtz, Edward M. Johnson, 2005, Biochemical and biophysical research communications.

Abstract 1632: Co-targeting mTOR and IGF-1R/IR results in synergistic activity against a broad array of tumor cell lines, independent ofKRASmutation status

D. Epstein, M. Miglarese, S. Russo, 2010 .

Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions

S. Thomson, F. Petti, Izabela Sujka-Kwok, 2008, Clinical & Experimental Metastasis.

A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies

P. LoRusso, D. Tan, S. Kaye, 2016, British Journal of Cancer.

Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells

L. Platanias, B. Druker, N. Donato, 2010, Proceedings of the National Academy of Sciences.

Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition

J. Haley, N. Gibson, E. Buck, 2007, Molecular Cancer Therapeutics.

Abstract B1: Dual mTORC1/mTORC2 inhibition limits tumor growth, VEGF production and vascular regrowth

D. Epstein, M. Miglarese, Beverly L. Falcón, 2012, Clinical Cancer Research.

Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies.

K. Flatten, B. Smith, J. Karp, 2012, Blood.

Dual mTORC2/mTORC1 Targeting Results in Potent Suppressive Effects on Acute Myeloid Leukemia (AML) Progenitors

A. Redig, L. Platanias, J. Altman, 2011, Clinical Cancer Research.

Workflow improvement and impact of the new Beckman Coulter LH 1500 high throughput automated hematology workcell.

Anthony D La Porta, A Shalea Bowden, Sharon Barr, 2004, Laboratory hematology : official publication of the International Society for Laboratory Hematology.

Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells

L. Platanias, B. Druker, N. Donato, 2010, Proceedings of the National Academy of Sciences of the United States of America.

Dual Inhibition of mTORC1/mTORC2 Induces Apoptosis of Mantle Cell Lymphoma by Preventing Rictor Mediated AKTS473 Phosphorylation by Potentiating AKT2-PHLPP1 Association

S. Kaufmann, T. Witzig, Mamta Gupta, 2010 .